Expert Review of Vaccines, Volume 14, Issue 9 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Vaccines, Volume 14, Issue 9 (2015)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
The case for vaccine development in the strategy to eradicate river blindness (onchocerciasis) from Africa
Benjamin L Makepeace, Simon A Babayan, Sara Lustigman & David W Taylor
Pages: 1163-1165
Published online: 19 Jun 2015
AbstractforThe case for vaccine development in the strategy to eradicate river blindness (onchocerciasis) from Africa | Full Text | References | PDF (486.8 KB)
  • 1728 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access

Vaccine Profile

The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis
Elina O Erra & Anu Kantele
Pages: 1167-1179
Published online: 10 Jul 2015
AbstractforThe Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis | Full Text | References | PDF (325.9 KB)
  • 496 Views
  • 23 CrossRef citations
  • 0Altmetric

Review

Review
Bioreactor concepts for cell culture-based viral vaccine production
Lilí Esmeralda Gallo–Ramírez, Alexander Nikolay, Yvonne Genzel & Udo Reichl
Pages: 1181-1195
Published online: 15 Jul 2015
AbstractforBioreactor concepts for cell culture-based viral vaccine production | Full Text | References | PDF (272 KB) | Supplemental
  • 19052 Views
  • 67 CrossRef citations
  • 0Altmetric
Open Access
Review
Gold nanoparticles and vaccine development
Jorge Alberto Salazar-González, Omar González-Ortega & Sergio Rosales-Mendoza
Pages: 1197-1211
Published online: 07 Jul 2015
AbstractforGold nanoparticles and vaccine development | Full Text | References | PDF (826.8 KB)
  • 868 Views
  • 61 CrossRef citations
  • 0Altmetric
Review
Rodents as pre-clinical models for predicting vaccine performance in humans
Peggy Riese, Stephanie Trittel, Kai Schulze & Carlos A Guzmán
Pages: 1213-1225
Published online: 12 Aug 2015
AbstractforRodents as pre-clinical models for predicting vaccine performance in humans | Full Text | References | PDF (344.2 KB)
  • 201 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity
Adam Kenneth Wheatley & Stephen John Kent
Pages: 1227-1239
Published online: 15 Jul 2015
AbstractforProspects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity | Full Text | References | PDF (660.6 KB)
  • 533 Views
  • 12 CrossRef citations
  • 0Altmetric
Review
Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations
Negar Aliabadi, Ben A Lopman, Umesh D Parashar & Aron J Hall
Pages: 1241-1253
Published online: 29 Jul 2015
AbstractforProgress toward norovirus vaccines: considerations for further development and implementation in potential target populations | Full Text | References | PDF (319.7 KB)
  • 577 Views
  • 36 CrossRef citations
  • 0Altmetric
Review
Applications of bacillus Calmette–Guerin and recombinant bacillus Calmette–Guerin in vaccine development and tumor immunotherapy
Yuan-qiang Zheng, Youssef W Naguib, Yixuan Dong, Yan-chun Shi, Shorgan Bou & Zhengrong Cui
Pages: 1255-1275
Published online: 12 Aug 2015
AbstractforApplications of bacillus Calmette–Guerin and recombinant bacillus Calmette–Guerin in vaccine development and tumor immunotherapy | Full Text | References | PDF (505.8 KB)
  • 205 Views
  • 37 CrossRef citations
  • 0Altmetric
Review
Multivalent meningococcal serogroup B vaccines: challenges in predicting protection and measuring effectiveness
Jan T Poolman & Peter Richmond
Pages: 1277-1287
Published online: 23 Jul 2015
AbstractforMultivalent meningococcal serogroup B vaccines: challenges in predicting protection and measuring effectiveness | Full Text | References | PDF (340.1 KB)
  • 536 Views
  • 13 CrossRef citations
  • 0Altmetric

Original Research

Article
Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice
Nian-Zhang Zhang, Ying Xu, Meng Wang, Eskild Petersen, Jia Chen, Si-Yang Huang & Xing-Quan Zhu
Pages: 1289-1297
Published online: 25 Jun 2015
AbstractforProtective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice | Full Text | References | PDF (1.1 MB)
  • 330 Views
  • 35 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination
Cynthia Burman et al.
Review Article | Published online: 7 Jun 2024
Open Access
Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs)
Kimberly M. Thompson et al.
Article | Published online: 7 Jun 2024
Open Access
Impact of rotavirus vaccination on diarrheal disease burden of children in South America
Tanmoy Bose et al.
Review Article | Published online: 31 May 2024
Open Access
Research progress on the quality control of mRNA vaccines
Chaoying Hu et al.
Review Article | Published online: 24 May 2024
Open Access